Table 2.
Experimental details, strengths, and limitations of models of necrotizing enterocolitis in mice
| Experimental Details | Strengths | Limitations | References |
|---|---|---|---|
| Formula feeding, hypoxia and hypothermia in preterm or term mice delivered by cesarean section. | Preterm pups. | Technical challenges of handling premature pups. | 30, 44, 49, 59, 71 |
| Clinical NEC does not occur immediately after birth so the clinical relevance is somewhat in question. | |||
| Formula feeding, hypoxia and hypothermia in mice delivered by cesarean section, with the addition of commensal bacteria obtained from adult mice. | Preterm pups. | Difficulty in handling preterm pups. | 10, 16, 68 |
| High NEC incidence. | Clinical NEC does not occur immediately after birth. | ||
| Addition of commensal bacteria increases clinical relevance. | |||
| Formula feeding and hypoxia in 10-day-old mice. | Technically easier to handle the 10-day-old mice. | The model does not use preterm pups. | 2, 3, 4, 5, 20, 39, 42, 64, 63, 74, 75, 83, 86, 95, 103 |
| NEC is induced at a time in which it is observed clinically within the postnatal period. | |||
| Ischemia and reperfusion by surgical occlusion of both superior mesenteric vessels. | More accurately is an oxidative stress model. | Clinical NEC does not involve occlusion of the mesenteric vessels, so the relevance of this model is uncertain. | 61 |
| Implantation of human fetal ileum subcutaneously into SCID mice. | Allows for interrogation of human tissue. | Requirement for human fetal tissue. | 73, 34 |
| Technically challenging. |